Intec Pharma Ltd. (NASDAQ: NTEC) Starts Presentation at 12th Annual LD Micro Main Event
Intec Pharma (NASDAQ: NTEC) is a clinical-stage biopharmaceutical company focused on developing drugs based on its proprietary Accordion Pill platform technology. The company's Accordion Pill is an oral drug delivery system designed to improve the efficacy and safety of existing drugs and drugs in development by utilizing an efficient gastric retention and specific release mechanism. In addition, the company has a feasibility agreement for the development of a custom-designed Accordion Pill for a proprietary compound with Novartis Pharmaceuticals and a research collaboration with Merck & Co. For more information, visit the company’s website at www.intecpharma.com. About NetworkNewsWire NetworkNewsWire (NNW) is…







